Gentian Diagnostics presents at DNB conference in New York

Moss 05.12.19
The CEO of Gentian Diagnostics, Dr. Hilja Ibert, will today give a company presentation at the DNB Nordic American Life Science conference in New York. Please find the presentation attached.

For further information, please contact

Hilja Ibert CEO, Gentian Diagnostics AS
E-mail: hilja.ibert@gentian.no
+47 919 05 242

Njaal Kind CFO, Gentian Diagnostics AS
E-mail: njaal.kind@gentian.no
+47 919 06 525

You may also read

Mar 20, 2026 - Ole Sørlie

Gentian Diagnostics: Annual report 2025

Moss, 20 March 2026 Gentian Diagnostics has today published its annual report for 2025. The annual report and..

Mar 12, 2026 - Ole Sørlie

Gentian Diagnostics ASA – Mandatory notification of subscription of shares by primary insiders in Employee Share Purchase Program

Moss, 12 March 2026 Reference is made to Gentian Diagnostics ASA's (the "Company") stock exchange..

Mar 12, 2026 - Ole Sørlie

Gentian Diagnostics ASA – Employee Share Purchase Program and share capital increase

Moss, 12 March 2026 Gentian Diagnostics ASA (the "Company") has completed the offer of new shares to..